Arcadia Biosciences Inc

NASDAQ RKDA

Data sourced from

and

Daily

Download Data

Arcadia Biosciences Inc Price to Earnings Ratio (P/E) on June 03, 2024: 4.77

Arcadia Biosciences Inc Price to Earnings Ratio (P/E) is 4.77 on June 03, 2024, a 3,031.96% change year over year. The price to earnings ratio (P/E ratio) compares the market price per share of a company's stock to its earnings per share (EPS). It is calculated by dividing the market capitalization by the net income, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's earnings. A higher P/E ratio indicates that investors are willing to pay a higher price for each unit of earnings, suggesting higher market expectations for future earnings growth.

Arcadia Biosciences Inc 52-week high Price to Earnings Ratio (P/E) is 5.41 on May 16, 2024, which is 13.54% above the current Price to Earnings Ratio (P/E).
Arcadia Biosciences Inc 52-week low Price to Earnings Ratio (P/E) is -0.36 on March 27, 2024, which is -107.53% below the current Price to Earnings Ratio (P/E).
Arcadia Biosciences Inc average Price to Earnings Ratio (P/E) for the last 52 weeks is 0.12.

NASDAQ: RKDA

Arcadia Biosciences Inc

CEO	Ms. Pamela Haley
IPO Date	May 15, 2015
Location	United States
Headquarters	202 Cousteau Place, Davis, CA, United States, 95618
Employees	21
Sector	Consumer Defensive
Industry	Packaged foods

Description

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Key trends